Author: BusinessWire

Sustained, clinically meaningful bilateral improvement in visual functions 96 weeks after injection Observed bilateral improvement interpreted as clearly superior to…

MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biopharmaceutical company which specialises in the development of…

Technology produces novel heavy chain-only antibodies for bi-specific, single domain antibodies or CAR-Ts CAMBRIDGE, Mass. & ROTTERDAM, The Netherlands, &…

WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX) announced today that Scott Tarriff, Chief Executive Officer,…

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)…

KENILWORTH, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24MRK&src=ctag" target="_blank"gt;$MRKlt;/agt; lt;a href="https://twitter.com/hashtag/MRK?src=hash" target="_blank"gt;#MRKlt;/agt;–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today…

WATERTOWN, Mass.–(BUSINESS WIRE)–Lyra Therapeutics, Inc., a clinical-stage biotechnology company developing medicines precisely designed to target ear, nose and throat (ENT)…

LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CancerTherapeutics?src=hash" target="_blank"gt;#CancerTherapeuticslt;/agt;–The global throat cancer therapeutics market is expected to post a CAGR of close to 7% during…

DUBLIN–(BUSINESS WIRE)–The “Global Eye Allergy Therapeutics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. This is expected to propel…

DUBLIN–(BUSINESS WIRE)–The “Global Attention deficit Hyperactivity Disorder (ADHD) Drugs Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The attention…